Stock JNH JACK NATHAN MEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jack Nathan Medical Corp.

Equities

JNH

CA4663771083

Healthcare Facilities & Services

Delayed Toronto S.E.
Other stock markets
 16:13:02 14/05/2024 BST 		5-day change 1st Jan Change
0.045 CAD 0.00% Intraday chart for Jack Nathan Medical Corp. 0.00% 0.00%
04-30 Jack Nathan Medical Corp. Reports Earnings Results for the Full Year Ended January 31, 2024 CI
2023 Jack Nathan Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023 CI

Valuation

Fiscal Period: January 2021 2022 2023 2024
Capitalization 1 68.87 16.68 6.746 3.484
Enterprise Value (EV) 1 61.89 16.78 9.835 12.81
P/E ratio -4.43 x -2 x -1 x -0.52 x
Yield - - - -
Capitalization / Revenue 17.9 x 1.73 x 0.44 x 0.18 x
EV / Revenue 16.1 x 1.74 x 0.63 x 0.67 x
EV / EBITDA -88.3 x -2.75 x -2.23 x -2.97 x
EV / FCF -77,448,384 x -12,075,818 x -3,519,045 x -1,810,998 x
FCF Yield -0% -0% -0% -0%
Price to Book 8.07 x 4.09 x -3.61 x -0.59 x
Nbr of stocks (in thousands) 81,020 83,410 84,330 87,099
Reference price 2 0.8500 0.2000 0.0800 0.0400
Announcement Date 31/05/21 31/05/22 01/06/23 30/04/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: January 2019 2020 2021 2022 2023 2024
Net sales 1 2.925 3.617 3.852 9.639 15.49 19.14
EBITDA 1 0.7783 0.2232 -0.7009 -6.104 -4.412 -4.31
EBIT 1 0.754 0.1531 -0.8054 -6.549 -5.199 -5.201
Operating Margin 25.77% 4.23% -20.91% -67.95% -33.57% -27.16%
Earnings before Tax (EBT) 1 2.781 -1.38 -10.29 -8.233 -6.989 -7.442
Net income 1 2.107 -1.356 -9.903 -7.808 -6.903 -6.636
Net margin 72.05% -37.5% -257.05% -81% -44.57% -34.66%
EPS 2 0.6322 -0.4069 -0.1918 -0.1000 -0.0800 -0.0776
Free Cash Flow - -0.5587 -0.7991 -1.389 -2.795 -7.073
FCF margin - -15.45% -20.74% -14.41% -18.04% -36.94%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 24/09/20 24/09/20 31/05/21 31/05/22 01/06/23 30/04/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: January 2019 2020 2021 2022 2023 2024
Net Debt 1 0.04 1.1 - 0.09 3.09 9.32
Net Cash position 1 - - 6.98 - - -
Leverage (Debt/EBITDA) 0.0487 x 4.925 x - -0.0153 x -0.6999 x -2.163 x
Free Cash Flow - -0.56 -0.8 -1.39 -2.79 -7.07
ROE (net income / shareholders' equity) - 314% -268% -127% -623% 170%
ROA (Net income/ Total Assets) - 3.99% -8.16% -43.6% -44.5% -36.9%
Assets 1 - -33.98 121.4 17.92 15.5 18
Book Value Per Share 2 0.0800 -0.1100 0.1100 0.0500 -0.0200 -0.0700
Cash Flow per Share 2 0.1400 - 0.0900 0.0100 0.0200 0.0400
Capex 1 0.27 0.26 0.5 0.95 2.59 4.09
Capex / Sales 9.37% 7.06% 12.97% 9.87% 16.7% 21.36%
Announcement Date 24/09/20 24/09/20 31/05/21 31/05/22 01/06/23 30/04/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
JACK NATHAN MEDICAL CORP. Stock Jack Nathan Medical Corp.
0.00% 2.86M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+17.00% 83.07B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.67% 70.89B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+3.59% 28.32B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-7.90% 17.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+2.07% 17.43B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+0.37% 15.64B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+6.95% 13.46B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+8.40% 12.82B
NATERA, INC. Stock Natera, Inc.
+69.24% 12.69B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. JNH Stock
  4. Financials Jack Nathan Medical Corp.